Molecular mechanism and structural basis of gain-of-function of STAT1 caused by pathogenic R274Q mutation

Ryoji Fujiki1, Atsushi Hijikata2, Tsuyoshi Shirai2

  • 1From the Department of Technology Development, Kazusa DNA Research Institute, 2-6-7 Kazusa-Kamatari, Kisarazu-Shi, Chiba-Ken, 292-0818, fujiki@kazusa.or.jp.

Insights

Gain-of-function mutations in Signal Transducer and Activator of Transcription 1 (STAT1) cause chronic mucocutaneous candidiasis. A novel mechanism reveals how the R274Q mutation enhances STAT1 activity by disrupting dimer formation.

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • Gain-of-function (GOF) mutations in Signal Transducer and Activator of Transcription 1 (STAT1) are implicated in chronic mucocutaneous candidiasis (CMC).
  • The precise molecular mechanisms underlying STAT1 GOF in CMC remain incompletely understood.
  • Structural insights into pathogenic STAT1 mutations are crucial for elucidating disease pathogenesis.

Purpose of the Study:

  • To investigate the structural and functional impact of STAT1 GOF residues, particularly those in the coiled-coil domain, on STAT1 function.
  • To elucidate the molecular basis of STAT1 gain-of-function in chronic mucocutaneous candidiasis.
  • To identify novel mechanisms driving STAT1 GOF mutations.

Main Methods:

  • Construction and transcriptional activity measurement of STAT1 alanine mutants at α3 helix residues.
  • Structural analysis of STAT1 GOF residues within the coiled-coil domain and at dimer interfaces.
  • RNA-sequencing analysis of STAT1-deficient epithelial cells and primary T cells from CMC patients with the R274Q mutation.

Main Results:

  • Identified STAT1 GOF residues located within the coiled-coil domain or at the anti-parallel dimer interface.
  • The Arg-274 mutation was found adjacent to the DNA-binding domain and functionally interacted with Gln-441, potentially impeding dimer formation.
  • RNA-seq analysis showed the R274Q mutation altered expression of specific RefSeq genes, indicating increased transcriptional activity without a broad change in STAT1 targets.

Conclusions:

  • The Arg-274 mutation in STAT1 provides a novel mechanism for gain-of-function by disrupting dimer formation and modulating transcriptional activity.
  • This study enhances understanding of the molecular basis of STAT1 GOF in chronic mucocutaneous candidiasis.
  • The findings highlight the importance of structural integrity at the dimer interface for normal STAT1 function.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.5K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.9K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.6K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
9.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.0K